Dr. Jackson's project is "Decision Support Tools in Reducing Racial Disparities in Oral Anticoagulation use in Atrial Fibrillation."
Jackson’s overall research aim is to apply the principles of shared decision-making to enhance patient-centered care and ultimately reduce disparities in the treatment of atrial fibrillation in racial and ethnic minorities. His REACH Equity project will determine patient (African American and white) and provider factors associated with acceptance or refusal of oral anticoagulants (OAC) for stroke prevention in patients with nonvalvular atrial fibrillation and develop an evidence-based decision support tool to reduce racial disparities in OAC use.
The Career Development Awards support mentored research projects for junior faculty focusing on the REACH Equity theme: addressing racial and ethnic disparities in health by developing and testing interventions that improve the quality of patient-centered care in the clinical encounter – a setting in which racial and ethnic disparities are well-documented.
The REACH Equity Career Development Award program is directed by Laura P. Svetkey, MD, MHS, professor of medicine (Nephrology) and associate director of the REACH Equity Center. Scholars engage in mentored research and a career development program provided by the REACH Equity Center that includes a core curriculum, a works-in-progress seminar series, and an annual disparities research colloquium. Prior to the end of the 2-year award period, each scholar is expected to submit a grant application for next-stage funding.
Kimberly S. Johnson, MD, director of the REACH Equity Center, said Duke selected these four scholars from an impressively competitive pool of applicants.
“Our inaugural group of REACH Equity scholars has made impressive progress in their first year. I am extremely excited to welcome this outstanding second cohort of scholars," Johnson said. "Their proposals provide creative solutions to developing and testing interventions that address health disparities in the clinical encounter across disciplines, diseases, and age groups. I look forward to working with them over the next 2 years of their REACH Equity support and beyond.”